Search Results

You are looking at 1 - 1 of 1 items for

  • Author: Antonella Pedrini x
Clear All Modify Search
Nella Augusta Greggio Endocrinology and Adolescence Unit, Department of Woman and Child Health, University of Padova, Padova, Italy

Search for other papers by Nella Augusta Greggio in
Google Scholar
PubMed
Close
,
Elisa Rossi CINECA – Interuniversity Consortium (Health Service), Bologna, Italy

Search for other papers by Elisa Rossi in
Google Scholar
PubMed
Close
,
Silvia Calabria CORE srl – Collaborative Outcome Research, Bologna, Italy

Search for other papers by Silvia Calabria in
Google Scholar
PubMed
Close
,
Alice Meneghin Endocrinology and Adolescence Unit, Department of Woman and Child Health, University of Padova, Padova, Italy

Search for other papers by Alice Meneghin in
Google Scholar
PubMed
Close
,
Joaquin Gutierrez de Rubalcava Endocrinology and Adolescence Unit, Department of Woman and Child Health, University of Padova, Padova, Italy

Search for other papers by Joaquin Gutierrez de Rubalcava in
Google Scholar
PubMed
Close
,
Carlo Piccinni CORE srl – Collaborative Outcome Research, Bologna, Italy

Search for other papers by Carlo Piccinni in
Google Scholar
PubMed
Close
, and
Antonella Pedrini CORE srl – Collaborative Outcome Research, Bologna, Italy

Search for other papers by Antonella Pedrini in
Google Scholar
PubMed
Close

Objective

To estimate the prevalence of subclinical hypothyroidism (SH) among children, by using levothyroxine low dosage as disease proxy, and to describe prescription pattern.

Design

An historical cohort study was performed through administrative databases of 12 Italian Local Health Units covering 3,079,141 inhabitants. A cohort of children (aged 0–13 years) was selected in the period 2001–2014. A subgroup of new users (aged 0–9 years) was identified and followed up for 5 years.

Methods

The prevalence was provided as mean value of the whole period, as annual trend, by patient gender and age. Demographic details, information on levothyroxine dosage, comorbidities and co-medications were provided. Therapy duration and medication persistence were evaluated among new users.

Results

644 children treated with levothyroxine low dosage was selected, with a mean annual prevalence of 0.20 per 1000 children. The temporal trend of prevalence was stable, with a slight reduction in the 2005–2008. Prevalence by age showed an increase after 10 years. Patients were treated with an average annual dose of 4290 µg/year and 66.9% of children were affected by comorbidities. Among 197 new users, 62.9% received therapy only for one year, whereas out of those treated two or more years, 89.0% resulted persistent to the therapy.

Conclusions

This study provides real-world epidemiology of SH among children, and it depicts the clinical and therapeutic characteristics of these subjects. Its findings showed that the SH treatment of this disorder was widely variable, also due to lack of evidence concerning paediatric population.

Open access